CSIR-IICT, Lee Pharma sign agreement to produce 2-D
Lee Pharma will manufacture and commercialise the 2-DG sachets from their formulation facility located at SEZ, Duvvada,…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Lee Pharma
Lee Pharma to launch favipiravir under brand name Faravir at Rs 27 per tablet
It has got DCGI nod to manufacture and market favipiravir APIs
Pharma MSMEs ask government to extend incentives of PLI scheme
Due to incremental sales and production provisions of the PLI scheme, the MSME sector is not able to avail the desired benefits
Remdesivir in India: An unfolding story
Remdesivir has emerged as one of the most promising drug candidates for the treatment of COVID-19. But, is it affordable for…
Amid patent debate, BDR Pharma and Lee Pharma give up battle to copy drugs
Blames lack of government support for cheap generics and pressure from Big Pharma Drugmakers BDR Pharma and Lee Pharma have given…
Lee Pharma files India’s 3rd CL
Targets AstraZeneca’s saxagliptin
Hyderabad-based Lee Pharma became the third Indian pharma company to tap the compulsory licence…